Etanercept in axial spondyloarthritis – treatment efficacy
The beginning of the 21st century was marked by a simultaneous changes in view on pathogenesis, diagnostics and treatment of axial spondyloarthritis (axSpA). Anti-TNFα inhibitors were the first biologics prescribed in axSpA. 20 year after the biological treatment was first prescribed we have enough...
Saved in:
Main Authors: | I. Z. Gaydukova, O. V. Inamova, R. R. Samigullina, A. L. Chudinov, A. S. Bychkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2022-03-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3113 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
by: S. A. Lapshina, et al.
Published: (2016-09-01) -
CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01) -
Axial spondyloarthritis: a current look at the concept and evolution of the disease
by: D. G. Rumyantseva, et al.
Published: (2019-10-01) -
Progression of sacroiliitis in men and women according to the cohort of early axial spondyloarthritis (CORSAR) over 3 years of follow-up
by: D. G. Timokhina, et al.
Published: (2021-12-01) -
COMPARATIVE EVALUATION OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
by: I. А. Cherentsova, et al.
Published: (2016-09-01)